Browse > Article
http://dx.doi.org/10.4014/jmb.1008.08012

Synthesis and Optimization of Cholesterol-Based Diquaternary Ammonium Gemini Surfactant (Chol-GS) as a New Gene Delivery Vector  

Kim, Bieong-Kil (School of Life Sciences and Biotechnology, Kyungpook National University)
Doh, Kyung-Oh (Department of Physiology, Yeungnam University School of Medicine)
Bae, Yun-Ui (Department of Physiology, Yeungnam University School of Medicine)
Seu, Young-Bae (School of Life Sciences and Biotechnology, Kyungpook National University)
Publication Information
Journal of Microbiology and Biotechnology / v.21, no.1, 2011 , pp. 93-99 More about this Journal
Abstract
Amongst a number of potential nonviral vectors, cationic liposomes have been actively researched, with both gemini surfactants and bola amphiphiles reported as being in possession of good structures in terms of cell viability and in vitro transfection. In this study, a cholesterol-based diquaternary ammonium gemini surfactant (Chol-GS) was synthesized and assessed as a novel nonviral gene vector. Chol-GS was synthesized from cholesterol by way of four reaction steps. The optimal efficiency was found to be at a weight ratio of 1:4 of lipid:DOPE (1,2-dioleoyl-L-${\alpha}$- glycero-3-phosphatidylethanolamine), and at a ratio of between 10:1~15:1 of liposome:DNA. The transfection efficiency was compared with commercial liposomes and with Lipofectamine, 1,2-dimyristyloxypropyl-3-dimethylhydroxyethylammonium bromide (DMRIE-C), and N-[1-(2,3-dioleoyloxy)propyl]-N,N,N-trimethylammonium chloride (DOTAP). The results indicate that the efficiency of Chol-GS is greater than that of all the tested commercial liposomes in COS7 and Huh7 cells, and higher than DOTAP and Lipofectamine in A549 cells. Confirmation of these findings was observed through the use of green fluorescent protein expression. Chol-GS exhibited a moderate level of cytotoxicity, at optimum concentrations for efficient transfection, indicating cell viability. Hence, the newly synthesized Chol-GS liposome has the potential of being an excellent nonviral vector for gene delivery.
Keywords
Cholesterol; cationic liposome; gene therapy; gemini surfactant; transfection;
Citations & Related Records

Times Cited By Web Of Science : 4  (Related Records In Web of Science)
연도 인용수 순위
  • Reference
1 Woods, N. B., A. Muessig, M. Schmidt, J. Flygare, K. Olsson, P. Salmon, D. Trono, C. von Kalle, and S. N. B. Karlsson. 2003. Lentiviral vector transduction of NOD/SCID repopulating cells results in multiple vector integrations per transduced cell: Risk of insertional mutagenesis. Blood 101: 1284-1289.   DOI   ScienceOn
2 Yoshimura, T., S. Hasegawa, N. Hirashima, M. Nakanishi, and T. Ohwada. 2001. Anchoring and bola cationic amphiphiles for nucleotide delivery. Effects of orientation and extension of hydrophobic regions. Bioorg. Med. Chem. Lett. 11: 2897-2901.   DOI   ScienceOn
3 Zabner, J., A. J. Fasbender, T. Moninger, K. A. Poellinger, and M. J. Welsh. 1995. Cellular and molecular barriers to gene transfer by a cationic lipid. J. Biol. Chem. 270: 18997-19007.   DOI
4 Rosenzweig, H. S., V. A. Rakhmanova, and R. C. MacDonald. 2001. Diquaternary ammonium compounds as transfection agents. Bioconjug. Chem. 12: 258-263.   DOI   ScienceOn
5 Van der Woude, I., A. Wagenaar, A. A. Meekel, M. B. ter Beest, M. H. Ruiters, J. B. Engberts, and D. Hoekstra. 1997. Novel pyridinium surfactants for efficient, nontoxic in vitro gene delivery. Proc. Natl. Acad. Sci. USA 94: 1160-1165.   DOI   ScienceOn
6 Ilies, M. A., W. A. Seitz, B. H. Johnson, E. L. Ezell, A. L. Miller, E. B. Thompson, and A. T. Balaban. 2006. Lipophilic pyrylium salts in the synthesis of efficient pyridinium-based cationic lipids, gemini surfactants, and lipophilic oligomers for gene delivery. J. Med. Chem. 49: 3872-3887.   DOI   ScienceOn
7 Wang, J., X. Guo, Y. Xu, L. Barron, and F. C. Jr. Szoka. 1998. Synthesis and characterization of long chain alkyl acyl carnitine esters. Potentially biodegradable cationic lipids for use in gene delivery. J. Med. Chem. 41: 2207-2215.   DOI   ScienceOn
8 Li, Z., J. Dullmann, B. Schiedlmeier, M. Schmidt, C. von Kalle, J. Meyer, et al. 2002. Murine leukemia induced by retroviral gene marking. Science 296: 497.   DOI
9 Marshall, E. 2002. Gene therapy: What to do when clear success comes with an unclear risk. Science 298: 510-511.   DOI
10 Miller, A. D. 2003. The Problem with cationic liposome/ micelle-based non-viral vector systems for gene therapy. Curr. Med. Chem. 10: 1195-1211.   DOI   ScienceOn
11 Karmali, P. P. and A. Chaudhuri. 2007. Cationic liposomes as non-viral carriers of gene medicines: Resolved issues, open questions and future promises. Med. Res. Rev. 27: 696-722.   DOI   ScienceOn
12 Kasireddy, K., S. M. Ali, M. U. Ahmad, S. Choudhury, P. Y. Chien, S. Sheikh, and I. Ahmad. 2005. Synthesis of cationic cardiolipin analogues. Bioorg. Chem. 33: 345-362.   DOI   ScienceOn
13 Kay, M. A., J. C. Glorioso, and L. Naldini. 2001. Viral vectors for gene therapy: The art of turning infectious agents into vehicles of therapeutics. Nat. Med. 7: 33-40.   DOI   ScienceOn
14 Hope, M. J., B. Mui, S. Ansell, and Q. F. Ahkong. 1998. Cationic lipids, phosphatidyl-ethanolamine and the intracellular delivery of polymeric, nucleic acid-based drugs (Review). Mol. Membr. Biol. 15: 1-14.   DOI   ScienceOn
15 Friedmann, T. 1996. Human gene therapy - an immature genie, but certainly out of the bottle. Nat. Med. 2: 144-147.   DOI   ScienceOn
16 Hafez, I. M., N. Maurer, and P. R. Cullis. 2001. On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids. Gene Ther. 8: 1188-1196.   DOI   ScienceOn
17 Hollon, T. 2000. Researchers and regulators reflect on first gene therapy death. Nat. Med. 6: 6.   DOI   ScienceOn
18 Felgner, J. H., R. Kumar, C. N. Sridhar, C. J. Wheeler, Y. J. Tsai, R. Border, P. Ramsey, M. Martin, and P. L. Felgner. 1994. Enhanced gene delivery and mechanism studies with a novel series of cationic lipid formulations. J. Biol. Chem. 269: 2550-2561.
19 Bajaj, A., P. Kondiah, and S. Bhattacharya. 2007. Design, synthesis, and in vitro gene delivery efficacies of novel cholesterol-based gemini cationic lipids and their serum compatibility: A structure-activity investigation. J. Med. Chem. 50: 2432-2442.   DOI   ScienceOn
20 Bajaj, A., B. Paul, S. S. Indi, P. Kondaiah, and S. Bhattacharya. 2007. Effect of the hydrocarbon chain and polymethylene spacer lengths on gene transfection efficacies of gemini lipids based on aromatic backbone. Bioconjug. Chem. 18: 2144-2158.   DOI   ScienceOn
21 Felgner, P. L., T. R. Gadek, M. Holm, R. Roman, H. W. Chan, M. Wenz, J. P. Northrop, G. M. Ringold, and M. Danielsen. 1987. Lipofection: A highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl. Acad. Sci. USA 84: 7413-7417.   DOI   ScienceOn
22 Farhood, H., N. Serbina, and L. Huang. 1995. The role of dioleoyl phosphatidylethanol-amine in cationic liposome mediated gene transfer. Biochim. Biophys. Acta 1235: 289-295.   DOI   ScienceOn
23 Chien, P. Y., J. Wang, D. Carbonaro, S. Lei, B. Miller, S. Sheikh, S. M. Ali, M. U. Ahmad, and I. Ahmad. 2005. Novel cationic cardiolipin analogue-based liposome for efficient DNA and small interfering RNA delivery in vitro and in vivo. Cancer Gene Ther. 12: 321-328.   DOI   ScienceOn